Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04917744 · ClinicalTrials.gov registry record
Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 5
- Enrollment target
NCT04917744: Completed study, sponsored by Mayo Clinic.
NCT04917744 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04917744 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This study evaluates blood samples and compares levels of metabolites (levels of vitamins, carbohydrates, proteins, etc., that are in the blood), before and after the plasma exchange in patients scheduled to receive immunotherapy for their ovarian cancer. The information gained from this study may help researchers better understand the side effects from each treatment and possibly lessen those side effects for future treatments.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
- OTHER Medical Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2024-02-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04917744
The ClinicalTrials.gov registry entry for NCT04917744 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT04917744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04917744 about?
NCT04917744 is a clinical study titled "Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors". This study evaluates blood samples and compares levels of metabolites (levels of vitamins, carbohydrates, proteins, etc., that are in the blood), before and after the plasma exchange in patients scheduled to receive immunotherapy for their ovarian cancer. The information gained from this study may h...
What is the current status of trial NCT04917744?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-04-01. Estimated completion is 2024-02-17.
What interventions are being tested in trial NCT04917744?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT04917744?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.